Espansione’s low-level light therapy (LLLT) is a non-invasive, in-practice treatment that supports the management of dry eye disease and complex ocular surface conditions, including allergic eye disease.
Using multi-wavelength light energy, LLLT helps stimulate cellular metabolism, enhance mitochondrial activity, and modulate inflammatory pathways within periocular tissues. This may assist in reducing inflammation, improving meibomian gland function, and supporting overall ocular surface homeostasis.
LLLT can be incorporated into a broader treatment strategy alongside therapies such as lid hygiene, lubricants, and in-office procedures including intense pulsed light, providing clinicians with a complementary, evidence-informed option for patients with chronic, multifactorial ocular surface disease.
For ophthalmologists managing complex allergic and inflammatory presentations, Espansione’s LLLT offers a valuable adjunct to help improve patient comfort and treatment outcomes.
Contact: Ophthalmopro (AUS) 1300 578 288 or (NZ) 0800 578 288
